Ceapro Inc
XTSX:CZO
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| CA |
|
Ceapro Inc
XTSX:CZO
|
18.3m CAD |
Loading...
|
|
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
89.4B USD |
Loading...
|
|
| US |
|
Ecolab Inc
NYSE:ECL
|
85.9B USD |
Loading...
|
|
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
10.8T JPY |
Loading...
|
|
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
266B CNY |
Loading...
|
|
| CH |
|
Givaudan SA
SIX:GIVN
|
27.8B CHF |
Loading...
|
|
| US |
|
PPG Industries Inc
NYSE:PPG
|
28.4B USD |
Loading...
|
|
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK |
Loading...
|
|
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.3T INR |
Loading...
|
|
| CH |
|
Sika AG
F:SIKA
|
19.9B EUR |
Loading...
|
|
| US |
|
International Flavors & Fragrances Inc
NYSE:IFF
|
20.8B USD |
Loading...
|
Market Distribution
| Min | -10 058.3% |
| 30th Percentile | 20.4% |
| Median | 33.6% |
| 70th Percentile | 50.5% |
| Max | 717.4% |
Other Profitability Ratios
Ceapro Inc
Glance View
Ceapro, Inc. engages in the development and marketing of natural products for personal care, cosmetic, human, and animal health industries. The company is headquartered in Edmonton, Alberta. The firm's primary business activities relate to the development and marketing of various health and wellness products and technology relating to plant extracts. The firm operates through two segments: the active ingredient product technology industry and the cosmeceutical industry. The firm is engaged in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. The company supports the use of its extracts in cosmeceutical, nutraceutical and therapeutic products for humans and animals. Its pipeline Oat Beta Glucan and Avenanthramides. The Company’s wholly owned subsidiaries include Ceapro Technology Inc., Ceapro Active Ingredients Inc., Ceapro BioEnergy Inc., Ceapro (P.E.I) Inc., Ceapro USA Inc., and JuventeDC Inc.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Ceapro Inc is 41.1%, which is below its 3-year median of 47.1%.
Over the last 3 years, Ceapro Inc’s Gross Margin has decreased from 50.4% to 41.1%. During this period, it reached a low of 41.1% on Jan 31, 2024 and a high of 62.7% on Jun 30, 2022.
